N

Nexeon Medsystems Inc
OTC:NXNN

Watchlist Manager
Nexeon Medsystems Inc
OTC:NXNN
Watchlist
Price: 0.0001 USD
Market Cap: 197 USD

Nexeon Medsystems Inc
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nexeon Medsystems Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
N
Nexeon Medsystems Inc
OTC:NXNN
Income from Continuing Operations
-$2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Income from Continuing Operations
$2.8B
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Income from Continuing Operations
$2.9B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Income from Continuing Operations
$14B
CAGR 3-Years
21%
CAGR 5-Years
33%
CAGR 10-Years
19%
IDEXX Laboratories Inc
NASDAQ:IDXX
Income from Continuing Operations
$1B
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
19%
Intuitive Surgical Inc
NASDAQ:ISRG
Income from Continuing Operations
$2.8B
CAGR 3-Years
26%
CAGR 5-Years
21%
CAGR 10-Years
18%
No Stocks Found

Nexeon Medsystems Inc
Glance View

Market Cap
196.6 USD
Industry
Health Care

Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. The company is headquartered in West Palm Beach, Florida. The company went IPO on 2017-08-01. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology. In addition, the Company is developing and commercializing NNS, an implantable neurostimulation and recording platform. The Company’s wholly-owned subsidiaries include Nexeon Medsystems Europe, SARL (Nexeon Europe), Nexeon Medsystems Puerto Rico Operating Company Corporation (NXPROC) and Pulsus Medical LLC.

NXNN Intrinsic Value
Not Available
N

See Also

What is Nexeon Medsystems Inc's Income from Continuing Operations?
Income from Continuing Operations
-2.2m USD

Based on the financial report for Dec 31, 2017, Nexeon Medsystems Inc's Income from Continuing Operations amounts to -2.2m USD.

What is Nexeon Medsystems Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-171%

Over the last year, the Income from Continuing Operations growth was -171%.

Back to Top